NATIONAL CENTER FOR NANOSCIENCE AND TECHNOLOGY

Their core work

NANOCTR is China's premier nanoscience research center, headquartered in Beijing, specializing in the characterization, safety assessment, and computational modelling of engineered nanomaterials. Within EU projects, they contribute expertise in nanotoxicology, multi-scale material modelling, and regulatory-oriented safety testing — particularly for nanomaterials used in medical devices. Their work bridges fundamental nanomaterial science with practical risk assessment frameworks, helping establish safe-by-design strategies for advanced materials entering European and global markets.

What they specialise in

How they've shifted over time

NANOCTR's early H2020 involvement (2017–2019) concentrated on foundational nanomaterial characterization and computational modelling tools — QSAR, PBPK models, and web-based informatics platforms for grouping and classifying engineered nanomaterials. By 2021, their focus shifted toward applied safety: safe-and-sustainable-by-design strategies, regulatory adaptation, mixture toxicity, and medical device safety testing. The trajectory shows a clear move from building analytical and modelling tools toward using those tools for regulatory and market-ready safety validation.

NANOCTR is moving from computational nanosafety research toward regulatory-grade safety validation, making them increasingly relevant for partners bringing nanomaterials to market.

How they like to work

NANOCTR participates exclusively as a consortium partner, never as coordinator — consistent with their role as an international (non-EU) contributor bringing specialized Chinese nanoscience expertise into European projects. With 117 unique partners across 29 countries, they operate within large, multi-national consortia typical of major EU nanosafety initiatives. This broad network suggests they are a trusted specialist that European coordinators actively recruit for their domain knowledge.

NANOCTR has collaborated with 117 unique partners across 29 countries through just 4 projects, reflecting participation in very large EU nanosafety consortia. Their reach is genuinely global, bridging Chinese nanoscience with European regulatory and industrial partners.

What sets them apart

NANOCTR is one of very few Chinese research centers embedded in the European nanosafety research ecosystem, offering a direct bridge between Asian nanomaterial production knowledge and EU regulatory frameworks. Their consistent presence across the major H2020 nanosafety projects (ACEnano, NanoInformaTIX, SUNSHINE) signals that European consortia value their characterization and modelling capabilities. For consortium builders, they offer access to Chinese nanoscience infrastructure and datasets that few European partners can provide.

Highlights from their portfolio

• NanoInformaTIX
  Ambitious platform project combining QSAR, PBPK, systems biology, and multi-scale modelling into a sustainable nanoinformatics platform — the most computationally intensive of NANOCTR's projects.
• SAFE-N-MEDTECH
  Bridges nanosafety into the medical device sector, addressing life-cycle safety of nano-enabled medical technologies including in vitro diagnostics — a high-impact regulatory area.
• SUNSHINE
  Most recent project (2021–2024) focused on safe-and-sustainable-by-design for advanced multi-component nanomaterials, representing NANOCTR's latest strategic direction.